What have we learnt from mouse models of NPM-ALK-induced lymphomagenesis?

被引：0
|
作者：
S D Turner
D R Alexander
机构：
[1] The Babraham Institute,Laboratory of Lymphocyte Signalling and Development
[2] Babraham Research Campus,undefined
来源：
Leukemia | 2005年 / 19卷
关键词：
NPM-ALK; ALCL; oncogene; kinase;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The nucleophosmin-anaplastic lymphoma kinase (NPM-ALK) is generated as a t(2;5) chromosomal breakpoint product, typically in CD30+ anaplastic large cell lymphomas. Activation of the NPM-ALK tyrosine kinase by NPM dimerisation causes autophosphorylation at multiple tyrosine residues and the consequent recruitment of a ‘signalosome’ that couples the fusion protein to pathways regulating mitogenesis and apoptosis. This review focuses on recent advances in our understanding of the transforming signals induced by this fusion protein in mouse models.
引用
收藏
页码：1128 / 1134
页数：6
相关论文
共 50 条
  • [1] What have we learnt from mouse models of NPM-ALK-induced lymphomagenesis?
    Turner, SD
    Alexander, DR
    LEUKEMIA, 2005, 19 (07) : 1128 - 1134
  • [2] Determining the contribution of NPM1 heterozygosity to NPM-ALK-induced lymphomagenesis
    McDuff, Fiona K. E.
    Hook, C. Elizabeth
    Tooze, Reuben M.
    Huntly, Brian J.
    Pandolfi, Pier Paolo
    Turner, Suzanne D.
    LABORATORY INVESTIGATION, 2011, 91 (09) : 1298 - 1303
  • [3] What have we learnt from mouse models for the study of malaria?
    Wykes, Michelle N.
    Good, Michael F.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2009, 39 (08) : 2004 - 2007
  • [4] Ovarian physiology: What we have learnt from the mouse ...
    Monget, P
    Hembert, S
    Binart, N
    Gougeon, A
    Panthier, JJ
    M S-MEDECINE SCIENCES, 1999, 15 (02): : 141 - 147
  • [5] Mouse models of chronic lymphocytic leukemia and Richter transformation: what we have learnt and what we are missing
    Bertilaccio, Maria Teresa Sabrina
    Chen, Shih-Shih
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [6] Provoked models of asthma: what have we learnt?
    O'Byrne, P. M.
    Gauvreauw, G. M.
    Brannan, J. D.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2009, 39 (02): : 181 - 192
  • [7] What have we learnt from Vioxx?
    Krumholz, Harlan
    Ross, Joseph S.
    Presler, Amos H.
    Egilman, David S.
    BMJ-BRITISH MEDICAL JOURNAL, 2007, 334 (7585): : 120 - 123
  • [8] What Have We Learnt from 2020?
    Roach, V.
    AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 2021, 61 : 139 - 139
  • [9] What have we learnt from AIDS?
    Pinching, AJ
    JOURNAL OF CLINICAL PATHOLOGY, 1997, 50 (11) : 885 - 886
  • [10] What have we learnt from SARS?
    Weiss, RA
    McLean, AR
    PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 2004, 359 (1447) : 1137 - 1140
12345